Qiang Xu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Rheumatoid Arthritis

Cognitive Impairment

Top Venues

Neurology and therapy

International journal of rheumatic diseases

International urology and nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiao-Na Ma, Wei Feng, Shu-Lin Chen, Xiao-Qin Zhong, Chang-Song Lin, Qiang Xu
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study. Neurology and therapy 13 (3) (2024)
Qi Wu, Ming-Xue Zhao, Xiao-Shan Huang, Chang-Song Lin, Qiang Xu
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study. Lupus 33 (6) (2024)
Qi Wu, Ming-Xue Zhao, Xiao-Shan Huang, Chang-Song Lin, Qiang Xu
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study. Lupus 33 (6) (2024)
Xiao-Na Ma, Wei Feng, Shu-Lin Chen, Xiao-Qin Zhong, Chang-Song Lin, Qiang Xu
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study. Neurology and therapy (2024)
Qi Wu, Ming-Xue Zhao, Xiao-Shan Huang, Chang-Song Lin, Qiang Xu
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study. Lupus (2024)
Xiao-Na Ma, Wei Feng, Shu-Lin Chen, Xiao-Qin Zhong, Chang-Song Lin, Qiang Xu
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study. Neurology and therapy 13 (3) (2024)
Xiao-Na Ma, Wei Feng, Shu-Lin Chen, Xiao-Qin Zhong, Chang-Song Lin, Qiang Xu
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study. Neurology and therapy 13 (3) (2024)
Wei Feng, Xiao-Na Ma, Qi Wu, Xiao-Qin Zhong, Shu-Lin Chen, Chang-Song Lin, Qiang Xu
Serum 25-hydroxyvitamin D levels and dermatomyositis: A 2-sample mendelian randomization study. International journal of rheumatic diseases 27 (6) (2024)
Xiao-Na Ma, Wei Feng, Shu-Lin Chen, Xiao-Qin Zhong, Chang-Song Lin, Qiang Xu
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study. Neurology and therapy 13 (3) (2024)
Jing-Wen Chen, Jing-Yi Zhan, Si-Ping Liang, Xiao-Dan Wang, Chang-Song Lin, Qiang Xu
A patient with refractory proliferative lupus nephritis treated with telitacicept: A case report. International journal of rheumatic diseases (2023)
Wei Feng, Xiao-Qin Zhong, Xue-Xia Zheng, Qing-Ping Liu, Min-Ying Liu, Xiao-Bao Liu, Chang-Song Lin, Qiang Xu
The Underlying Mechanism of Duanteng Yimu Decoction in Inhibiting Synovial Hyperplasia in Rheumatoid Arthritis. Journal of immunology research 2023 (2023)
Kai-Jun Zhu, Wei Feng, Xiao-Na Ma, Pei-Lun Liao, Chang-Song Lin, Jing-Yang Huang, James Cheng-Chung Wei, Qiang Xu
Proton pump inhibitor use associated with an increased risk of gout: A population-based case-control study. International journal of rheumatic diseases (2023)
Shu-Lin Chen, Qiang Xu, Chang-Song Lin
Methotrexate is associated with decreased total thyroxine in patients with rheumatoid arthritis. Inflammopharmacology (2023)
Kai-Jun Zhu, Guo-Shu Deng, Li-Yu Zhang, Ye-Chun Yang, Qiang Xu, Ming-Ying Zhang
Association of neutrophil-to-lymphocyte ratio with renal impairment among patients with acute gouty arthritis. International urology and nephrology 54 (11) (2022)
Qiang Xu, Chang-Song Lin
An interesting tophus in gingiva. International journal of rheumatic diseases (2022)
Qiang Xu, Zhi-Shan Huang, Qing-Ping Liu, James Cheng-Chung Wei
Tofacitinib for sarcoidosis, a new potential treatment. International journal of rheumatic diseases 25 (11) (2022)
Qiang Xu, Chang-Song Lin, Cong-Qiu Chu
Disseminated tophaceous gout without renal impairment. Rheumatology (Oxford, England) 60 (11) (2021)